Ir diretamente para o conteúdo
Células endoteliais da veia safena humana (HSVEC)
Tecido
Saphenous vein
Doença
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Local da metástase
Not applicable (normal, non-tumorigenic primary cell)
Sinónimos
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Documentos

Células endoteliais da veia safena humana (HSVEC)

Primary cell · Número do produto 300699

Venous endothelium for bypass graft research

€1,220.00sem impostos nem portes de envio

Personalização / Recomendações

Feito por encomenda
1

01Informações gerais

Descrição

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Tecido
Saphenous vein
Doença
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Local da metástase
Not applicable (normal, non-tumorigenic primary cell)
Aplicações
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Sinónimos
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Doador

Idade do dador
Lot-specific (see CoA)
Etnia
Lot-specific (see CoA)

03Classificação

Organismo
Humano
Sexo
Específico do lote
Propriedades de crescimento
Aderente
Estatuto em matéria de OGM
Sem OGM
Detalhes sobre o estatuto dos OGM
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Nível de biossegurança
1

04Características

Morfologia
Cobblestone (endothelial)
Tipo de célula
Primary endothelial cells
Tumorigénico
No
Tempo de duplicação
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Manuseamento e cultura

Meio de cultura
Endothelial Cell Growth Medium
Atmosfera de incubação

37°C, 5% CO2, saturated humidity.

Suplementos
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Reagente de dissociação
Subculture reagents as recommended on the certificate of analysis
Revestimento do frasco
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subcultura

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Rácio de divisão
1 to 3
Densidade de sementeira
More than 6,000 cells/cm²
Renovação de fluidos
24 hours after seeding, then every 48 to 72 hours
Recuperação após o descongelamento

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Descongelamento e cultura
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Controlo de qualidade e criopreservação

Esterilidade

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Meio de congelação
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condições de armazenamento

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Condições de envio

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expressão e suscetibilidade

Antigénios de superfície
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Receptores expressos
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identificadores

Referência
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
Número de identificação fiscal do NCBI
9606
Cellosaurus
Not assigned